The National Institutes of Health, Belgium-based viral vector manufacturer Exothera and researchers at Dartmouth Health’s Dartmouth Hitchcock Medical Center and Dartmouth’s Geisel School of Medicine are working to develop and bring to market the first nasal COVID-19 vaccine.